Skip to main content
. Author manuscript; available in PMC: 2019 Jul 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2018 Oct 8;28(1):110–118. doi: 10.1158/1055-9965.EPI-18-0598

Table 1:

Characteristics of the lung cancer cases and controls

Cases Controls P1 P2

Demographics (n=262) Negative Scan N=418 Positive Scan N=110

Age
    Median (IQR) in years 64 (60–68) 64 (59–68) 64.5 (61–68) 0.50 0.57

Gender
    Male 159 263 59 0.56 0.21
    Female 103 155 51

Race
    White 488 384 104
    Black or African-American 22 19 3
    Asian 6 6 0 0.36 0.27
    American Indian or Alaskan Native 1 1 0
    Native Hawaiian or other Pacific Islander 3 3
    More than one race 5 4 1
    Missing 3 1 2

Smoking Status at Randomization
    Former 124 182 49 0.33 0.62
    Current 138 236 61

Pack-years of Smoking
    Median (IQR) in years 57 (43–76.5) 51 (43–76) 50 (42.4–69) 0.22 0.05

BMI
    Median (IQR) in years 26.4 (24.0–29.2) 26.6 (24.4–30.1) 26.2 (22.9–30.13) 0.06 0.77

Family History of Lung Cancer
    No 192 304 82 0.71 0.61
    Yes 57 84 21

Tumor Stage
    IA 160
    IB 25
    IIA 5
    IIIA 15
    IIIB 23
    IV 10
    Unable to assess 7

Tumor Histology
    Large cell carcinoma, NOS 6
    Large cell neuroendocrine carcinoma 2
    Tumorlet, NOS 14
    Oat cell carcinoma 1
    Small cell carcinoma 3
    Non-small cell carcinoma 21
    Squamous cell carcinoma 52
    Squamous cell carcinoma, keratinizing, NOS 6
    Squamous cell carcinoma, large cell, non-keratinizing 1
    Adenocarcinoma 87
    Carcinoid 2
    Bronchiolo-alveolar adenocarcinoma 40
    Bronchiolo-alveolar adenocarcinoma, non-mucinous 3
    Bronchiolo-alveolar adenocarcinoma, mixed 5
    Adenocarcinoma with mixed subtypes 3
    Papillary adenoma 6
    Signet ring cell carcinoma 5
    Acinar cell adenoma 3
    Mixed squamous cell and glandular papilloma 4
    Adenocarcinoma with squamous metaplasia 1
1

P denotes differences between controls with a negative LDCT scan and lung cancer patients

2

P denotes differences between controls with a positive LDCT scan and lung cancer patients